Exocrine Pancreatic Insufficiency in Dogs: Nutritional Welfare
Exocrine pancreatic insufficiency (EPI) causes severe malabsorption and weight loss in dogs due to lack of digestive enzymes, but is highly manageable with enzyme replacement.
Key Facts
- EPI results from loss of pancreatic acinar cells producing digestive enzymes
- German Shepherds and Rough Collies are predisposed, often due to pancreatic acinar atrophy
- Signs include chronic diarrhea, weight loss despite increased food intake, and ravenous appetite
- Enzyme replacement therapy (dried pancreatic extract) dramatically restores welfare
- Additional B12 supplementation is often needed as absorption is impaired
Welfare Considerations
EPI welfare suffering is severe without treatment — affected dogs lose weight dramatically despite voracious appetite, producing large volumes of malodorous feces. The combination of hunger (calories not absorbed despite eating), muscle wasting, and gastrointestinal discomfort creates significant welfare compromise. With enzyme replacement therapy, most EPI dogs respond remarkably — weight gain begins within days, feces normalize, and demeanor improves dramatically. Finding the optimal enzyme dose and timing for individual dogs requires some adjustment period. Long-term management is typically straightforward and allows excellent quality of life.
What You Can Do
- Begin enzyme replacement therapy without delay when EPI is diagnosed
- Work with your vet to find the optimal enzyme dose and timing
- Supplement cobalamin (B12) if levels are found to be low
- Feed multiple small meals daily with enzyme supplement mixed into food
- Monitor body weight regularly to assess treatment adequacy